Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.

During the past decade, Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian Urologic Oncology Group" with 1 trials as a collaborator, "Danish Head and Neck Cancer Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet" are "Advanced Colorectal Cancer" (1 trials), "Any Stage of Any Thymic Malignancy" (1 trials), "Any Stage of Lung Cancer (Any Histotype)" (1 trials), "Any Stage of Malignant Pleural Mesothelioma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet" in a lesser frequency.

Most popular intervention types in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet" are "Drug" (11 trials), "Other" (4 trials), "Genetic" (3 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (3 trials), "Nintedanib" (2 trials), "Placebo" (2 trials), "Tumour markers testing" (2 trials) and "Androgen Deprivation Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet" are 12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".